Metraipolis › archive › dc_ce5f670a25ee

Development and Assessment of a Novel Palmitoylation-Related lncRNA Signature for Prognosis and Immune Landscape in Hepatocellular Carcinoma — Europe PMC PMID:41613805

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41613805
DOI
10.32604/or.2025.070567
License (as archived)
solo-consultazione
Archived
2026-11-06T17:16:57.607Z
SHA-256 of the archived text
aca8639ff6c28f1c768201dd35983b63a3a99707d228bd1cf312b6f45082e2be
Stable URL of this page
https://metraipolis.com/documento/dc_ce5f670a25ee

How to cite

Development and Assessment of a Novel Palmitoylation-Related lncRNA Signature for Prognosis and Immune Landscape in Hepatocellular Carcinoma — Europe PMC PMID:41613805 — Europe PMC (en), https://europepmc.org/article/MED/41613805 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_ce5f670a25ee (Metraipolis archive dc_ce5f670a25ee, sha256 aca8639ff6c28f1c768201dd35983b63a3a99707d228bd1cf312b6f45082e2be)
BibTeX
@misc{dcce5f670a25ee,
  title = {Development and Assessment of a Novel Palmitoylation-Related lncRNA Signature for Prognosis and Immune Landscape in Hepatocellular Carcinoma — Europe PMC PMID:41613805},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41613805},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_ce5f670a25ee; sha256 aca8639ff6c28f1c768201dd35983b63a3a99707d228bd1cf312b6f45082e2be},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41613805. Agents can read the archived copy with the MCP tool read_document.